Thus, in ERα+/PR+/HER2− cells, the induction of greater CIN above the pre-existing CIN (before treatment) but below 70% (after treatment) indicates sensitivity to therapy (inhibition of cell proliferation). The gene discussed is ESR1; the disease is cervical squamous intraepithelial neoplasia.